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 Singleminded-2s (Sim2s) is a member of the basic helix- loop-helix Per-Arnt-Sim 
(bHLH-PAS) family of transcription factors.  Members of this family play important 
roles in sensing and responding to environmental changes, controlling circadian 
rhythms, and development.  Previous work in our laboratory found that Sim2s is down-
regulated in human breast cancer patients and cell lines and over-expression of Sim2s in 
highly invasive breast cancer cells blocks their proliferative and invasive potentials.  
Additionally, when Sim2s is knocked-down in MCF7 breast cancer cells, this normally 
relatively non-aggressive cell line becomes highly invasive and metastatic.   
 In the studies presented here, we found that over-expression of Sim2s in MCF7 
cells caused these cells to have a significant decrease in proliferative ability.  Propidium 
iodide flow cytometry showed more Sim2s cells in the G2/M and S phases of the cell 
cycle as compared to Empty controls.  While we observed no changes in cyclin or CDK 
levels between Empty controls and Sim2s cells, the regulatory protein p21 was found to 
be significantly up-regulated in Sim2s cells at both the RNA and protein levels.  





markers such as β-galactosidase staining, and Western blot analysis of Ki67 and 
H3K9Me2.  Based on these results, we hypothesize that over-expression of Sim2s 
triggers an up-regulation of p21, resulting in cellular senescence and cell cycle arrest.  
We also found that Sim2s cells are more highly sensitized to DNA damage through 
clonogenic survival assays.  Together, these studies support the idea that Sim2s is 
involved in cell cycle control by up-regulation of p21 resulting in cellular senescence 








This work is dedicated to my family.  Thank you for your constant love and 







 I would like to acknowledge my advisor, Dr. Weston Porter, for giving me the 
opportunity to explore all aspects of graduate school and giving me the freedom to 
actively pursue my interests.  I would also like to thank my committee members, Dr. 
Stephen Safe, Dr. Thomas Spencer, and especially Dr. Charles Long, for their help and 
advice.  I have to thank the past and present members of the Porter laboratory—without 
them life would have been a lot less interesting and a lot more difficult.  I want to thank 
Dr. Roger Smith for his help with all of the flow cytometry.  Finally, thank you to all of 
the people in the Genetics, Toxicology and VIBS departments who helped me so often 








ARNT Aryl Hydrocarbon Receptor Nuclear Translocator 
ATM Ataxia Telangectasia, mutated 
ATR ATM and RAD3 related 
bHLH basic Helix- loop-Helix  
CDK Cyclin Dependent Kinase 
CDKN1a Cyclin Dependent Kinase Inhibitor 1a (p21) 
ChIP Chromatin Immunoprecipitation 
CNS Central Nervous System 
DSB Double stranded break 
ECM Extracellular Matrix 
IR Irradiation 
MMTV Mouse mammary tumor virus 
PAS Per-Arnt-Sim 
PCNA Proliferating Cell Nuclear Antigen 
Q-PCR Quantitative PCR 
RT-PCR Reverse Transcriptase PCR 
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INTRODUCTION: CANCER, CELL CYCLE, p21-INDUCED SENESCENCE 
 
Overview of Cancer and Sim2s  
Cancer is the second most common cause of death in the United States, exceeded 
only by heart disease.  In 2009 alone 562,340 Americans were expected to die of 
cancer—nearly 1 of every 4 deaths (1).   
Breast cancer is the second leading cause of cancer-related deaths in U.S. women 
and the fourth leading cause of death in women overall.  In 2009, over 40,000 women 
died from this disease and 192,370 new cases were diagnosed.  While survival rates for 
women with breast cancer have been slowly increasing over the years due to better/early 
detection and improved treatment methods, it is important to further increase survival 
rates by developing better forms of treatment and ultimately preventative measures.  For 
this reason, research on breast cancer is extremely important.  The objective of our 
research with Singleminded2-s (Sim2s) is to ultimately contribute to this research and 
establish additional and improved forms of detection or treatment for breast cancer.  
Before we can reach that step, however, we need to establish how Sim2s functions in the 









Singleminded2-s (Sim2s) is a member of the basic helix- loop-helix Per-Arnt-Sim 
(bHLH/PAS) family of transcription factors.  This family includes members such as Per, 
Hif1α, and ARNT; factors involved in circadian rhythm, response to environmental 
stressors (hypoxia), and regulation of transcriptional responses to dioxins and polycyclic 
aryl hydrocarbons.  The PAS domain is highly conserved and has many important roles 
in sensing and binding to small molecules such as molecular oxygen, cellular 
metabolites, or polyaromatic hydrocarbons (2).   
Many PAS family members play important roles in regulating development.  In 
Drosophila, Single-minded (Sim) is required for synchronized cell division, proper 
formation of nerve cell precursors, and positive auto-regulation of central midline 
expression—thus making it a master developmental regulator of the CNS (3-4).  In 
mammals there are two different Sim homologs (Sim1 and Sim2).  Null mutations in 
both genes in mice have provided evidence that both genes are important for embryonic 
survival as both Sim1 and Sim2 knock-out mice die shortly after birth (5).  Work in mice 
has shown that Sim1 is required for development of several secretory neurons at the final 
stages of their differentiations (6).  Mice that have had Sim2 knocked-out die within 3 
days of birth due to lung atelectasis and breathing failure.  Additionally, these mice have 
congenital scoliosis, as observed in the unequal sizes of the left and right vertebrae and 
ribs.  The temporal and spatial expression patterns of Sim2 indicate that it could play a 
role in regulating skeletal growth and/or development (7).  
The Sim2 gene has a splice variant referred to as Sim2s.  This variant is missing 





and Sim2s repress Dioxin Response Elements (DREs) equally, however, they have 
differential responses in repressing Hypoxia Response Elements (HREs), with Sim2s 
having a less repressive effect.  Additionally, Sim2s can activate expression from a 
Central Midline Element (CME).  This implies that the Pro/Ala-rich sequence present in 
Sim2 but not Sim2s exerts a negative effect on CME-mediated gene expression (8).   
Our laboratory has previously shown that Sim2s is developmentally regulated in 
the mammary glands of mice and its expression peaks during the first week of lactation 
when the mammary gland is undergoing terminal differentiation.  Precocious expression 
of Sim2s in vivo promotes an alveolar cell phenotype.  Analysis of mammary glands 
from transgenic mice over-expressing  Sim2s under the Mouse Mammary Tumor Virus 
(MMTV-Sim2s) and wild-type (WT) mice found that mRNA levels of milk proteins 
including β-casein (Csn2) and whey acidic protein (WAP) were significantly increased 
in the mice over-expressing Sim2s (9-10).  Further, we hypothesized that Sim2s is 
involved in enhanced mammary gland differentiation because we observed an increase 
in the sodium phosphate transporter Npt2b (shown to be expressed in late pregnant and 
lactating mammary tissues) in transgenic mice (9-10).   
The Sim2 gene is found on Chromosome 21 (in humans) and 16 in mice 
(syntenic to Human Chromosome 21).  Transgenic mice with three copies of Sim2 
exhibit a slight Down Syndrome phenotype (11).  Additionally, these mice die at birth 
from complications due to breathing failure and display rib, vertebral and craniofacial 





Due to its location on Chromosome 21 in the Down Syndrome Critical Region, 
Sim2s plays an important role in the etiology of this disorder.  Sim2 mRNA is expressed 
in facial, skull, palate and vertebra primordia in human and rodent embryos and its 
trisomic state is suspected to contribute to the phenotypic features associated with Down 
Syndrome (DS), as well as, the anxiety-related/reduced exploratory behavior and 
sensitivity to pain phenotypes of DS individuals (11-12).  Like many genetic disorders, 
DS has a unique tumor profile.  These individuals have an increased incidence of 
leukemia and ovarian or testicular cancer, but a decreased incidence of solid tumors—in 
particular breast cancer (Figure 1).  In several age-matched control studies, individuals 
with DS were shown to have a significantly decreased incidence of breast cancer (13-
14). 
Because of this dramatically decreased incidence of breast cancer in these 
individuals, our laboratory is investigating the potential role of Sim2s as a tumor 
suppressor gene in the breast.  While Sim2s is shown to be up-regulated in prostate and 
pancreatic cancers, the supposed oncogenic mechanism has not been delineated, and like 
several genes such as KLF4, Sim2s could play a role as an onocogene in one tissue and a 























Figure 1.  Cancer incidences for individuals with Down syndrome.  Adapted 






  Initially we surveyed Sim2s expression in a variety of human breast cell lines. 
Interestingly, Sim2s levels were high in normal breast cells but severely decreased in 
breast cancer lines (Figure 2) (17).  Additionally, as the invasive potential of the breast 
cancer cell lines increased, Sim2s levels decreased.  To investigate the potential tumor 
suppressor activity, we over-expressed Sim2s in highly invasive MDA-MB-435 cells, 
which resulted in inhibited proliferation and invasive potential (Figure 3). 
Additionally, knock-down of Sim2s in the relatively non- invasive MCF7 breast 
cancer cell line resulted in an epithelial-mesenchymal transition (EMT) characterized by 
a spindled cell morphology with decreased epithelial characteristics and significantly 
elevated mesenchymal markers (Figure 4).  When control and Sim2s-deficient (Sim2i) 
MCF7 cells were injected into the flanks of nude mice, the Sim2i cells resulted in large, 
highly vascularized, estrogen receptor negative tumors.  Together, these results support a 





















Figure 2.  Expression levels of Sim2s were surveyed in a panel of human breast cell 
lines.  Sim2s levels were highly expressed in normal breast epithelial cells but decreased 














Figure 3.  Proliferation assay for MDA-MB-435 cells over-expressing Sim2s and Empty 
controls.  When Sim2s is over-expressed in the highly invasive MDA-MB-435 cell line, 














Figure 4.  Analysis of invasive potential and ECM markers in MCF7 cells with Sim2s 
knocked down.  A.  When Sim2s is knocked-down in the less- invasive breast cancer cell 
line MCF7 the invasiveness potential of these cells significantly increases.  B.  
Additionally, these cells appear to undergo an epithelial to mesenchymal like-transition, 
with epithelial markers like E-Cadherin becoming down-regulated and mesenchymal 












Cell Cycle Regulation 
Throughout the course of the cell cycle, mammalian cells coordinate several 
different physiological processes, including:  coordinating cell growth, genome 
replication, and cellular division.  There are four major parts of the cell cycle—G1, S, 
G2, and M, and each are regulated by a variety of signaling molecules and other 














Figure 5.  Graphical representation of the cell cycle.  Major cyclins and CDKs are 
shown, as well as some of the major factors required to push the cell through the 
various phases of the cell cycle.  Hyperphosphorylated Retinoblastoma is required 
to push the cell through the R-point (where it is no longer responsive to mitogenic 





Before a cell can begin to replicate its DNA in S-phase, it ―consults‖ its 
extracellular environment and responds to growth stimulating signals.  It is of particular 
note that cells are only susceptible to mitogenic signaling during the G1 phase.  
Mitogenic signaling through receptor tyrosine kinases and G-protein coupled receptors 
activate pathways such as Ras and PI3K to stimulate cell proliferation, growth, and 
survival—pushing the cell through G1.  The Ras-MEK-ERK kinase cascade promotes 
activation of CDK2 by ERK-dependent phosphorylation and stabilization of c-Myc.  
This, in turn, induces expression of cyclin D1 and suppresses CDK inhibitors (19).  The 
PI3K pathway is important for G1 because it activates Akt which inhibits glycogen 
synthase kinase 3-β (GSK3-β) and prevents it from destabilizing cyclin D.  The D- family 
of cyclins (D1, 2 and 3) is involved in regulating G1.  At the beginning of G1, a D-cyclin 
pairs with CDK4 or 6 (two very similar CDKs).  However, as Retinoblastoma (Rb) 
becomes more highly phosphorylated and drives the cell through the Restriction-point 
(R-point) CDK4 and 6 are replaced with CDK2, and cyclin D is replaced by cyclin E.  
After the cell passes through the R-point, it is no longer responsive to mitogenic 
signaling.   
In the beginning of S-phase, cyclin A replaces cyclin E and partners with CDK2.  
These complexes concentrate at the replication foci on chromosomes.  Initiation of DNA 
synthesis at replication origins is triggered by S-Cdks and Cdc7, an additional protein 
kinase.  Cdc7 activity is activated by binding to a regulatory subunit, Dbf4.  These 
protein kinases enable pre-replicative complexes (PRCs) to recruit DNA helicases, 





around the DNA template strand and move freely along it, thus beginning DNA 
replication.  As S-phase continues, cyclin A dissociates from CDK2 and partners with 
CDK1 (also known as CDC2).   
Before the cell can enter mitosis and divide into two cells, it passes through a 
second gap phase, G2.  During this phase the cell prepares itself for entry into mitosis.  
Starting in S-phase, transcription of cyclin B is up-regulated and while initially, in G2, 
cyclin A is bound to CDC2, as the cell moves further through this phase, cyclin A is 
replaced by cyclin B as it moves from the cytoplasm into the nucleus.  When cyclin B 
binds to CDC2 the complex is not activated until CDC2 is phosphorylated on T161 by 
Cdk-activating kinase (CAK).  CDC2 in complex with cyclin B remains active until late 
interphase of mitosis.  At this point, CDC2 is phosphorylated at T14 and Y15 which 
results in an inhibition of its kinase activity.  This phosphorylation activity is controlled 
by Wee1 and Myt1 kinases and Cdc25 phosphatases (20).   
After cells have gone through G2, they enter mitosis—which is composed of 
several different phases:  prophase, metaphase, anaphase and telophase.  An extremely 
complex array of proteins and other molecules regulate the cells transition through these 
steps.  After the cells have undergone mitosis, one parental cell results in two new 
daughter cells.   
 
Cellular Response to DNA Damage 
At each of the individual phases of the cell cycle there is a checkpoint to prevent 





factors involved in different pathways that can arrest cells at various checkpoints, only a 
few major ones will be discussed in this section.  The G1 checkpoint prevents damaged 
DNA from being replicated, while the S-phase checkpoint functions to monitor cell 
cycle progression and to react to DNA damage by decreasing synthesis.  The G2 
checkpoint is the final checkpoint that can prevent a cell with damaged DNA from 
replicating by suspending the cell cycle before chromosomes segregate.  There are two 
key regulators of the DNA damage pathway, Ataxia telangectasia, mutated (ATM) and 
ATM and Rad3 related (ATR) protein kinases.  These regulators affect cell cycle arrest 
at all three of the cell cycle checkpoints.  Usually, ATM is the primary response when a 
cell undergoes a DNA double strand break (DSB) upon exposure to ionizing radiation 
(IR).  ATR plays the main role in reacting to DSBs caused by UV damage and stalls in 
DNA replication, but also plays a back-up role when cells are exposed to IR. 
The G1 checkpoint is controlled by the ATM/ATR kinases which control the 
actions of p53.  When cells are exposed to ionizing radiation (IR), ATM phosphorylates 
T68 of Chk2 which then phosphorylates S20 of p53.  Phosphorylated S20 in p53 inhibits 
its interaction with MDM2, preventing p53 from being ubiquitinylated (21).  ATM can 
also directly inhibit MDM2 by phosphorylating it at S395, preventing its interaction with 
p53.  When p53 is up-regulated at the G1 checkpoint, it results in the activation of p21—
a cyclin-dependent kinase inhibitor which suppresses the kinase activity of cyclin E/cdk2 
and causes the cell to arrest in G1 (22). 
The S checkpoint is the least well understood of the three.  Some experiments 





has also been shown to activate Chk2).  This leads to hyperphosphorylation of Cdc25A 
and inhibition of the CDK2/cyclin E complex.  The result of this inhibition is decreased 
DNA replication origin firing and an activation of DNA repair pathways (23).  However, 
other experiments have shown that IR damage can activate the S-phase checkpoint by 
activating ATM which then phosphorylates T68 of Chk2.  This phosphorylation of Chk2 
targets Cdc25A for ubiquitinylation (by phosphorylating it at S123).  As the normal 
function of Cdc25A is to remove inhibitory phosphorylations (T14 and Y15) from Cdk2, 
without functional Cdc25A the CDK2/cyclin E and CDK2/cyclin A complexes are 
prevented from enabling DNA synthesis (24).   
At the G2 checkpoint in response to IR, UV, and genotoxic reagents, ATM/ATR 
phosphorylate Chk1/Chk2 which then phosphorylate Cdc25C at S216 (Figure 6).  When 
this site is phosphorylated it allows binding of 14-3-3 proteins.  The 14-3-3/Cdc25C 
protein complexes are sequestered in the cytoplasm.  This prevents Cdc25C from 
activating Cdc2 which inhibits Cdc2/Cyclin B1 complex formation and cell cycle 
progression.  This causes the cells to arrest in G2.  In response to damage, p53 
transcriptionally up-regulates expression of GADD45 and p21.  GADD45 is responsible 
for dissociating Cdc2 from cyclin B1 in response to damage and p21 interacts directly 
with Cdc2.  Both of these pathways enable the cell to arrest in G2 (25).  Alternatively, 
p21 can function independently of p53 activation—and can cause cell cycle arrest at all 

















In 1961 Hayflick observed that diploid cells in serial culture permanently stop 
dividing after approximately 50 passages.  These cells were irreversibly arrested and no 
longer able to divide despite being viable and metabolically active.  This state is known 
as cellular senescence and is characterized by the inability of cells to proliferate despite 
access to abundant nutrients and mitogens (26).  While there is evidence showing that 
cellular senescence in human cells is genetically controlled through telomere shortening, 
it can also be caused in response to loss of tumor suppressors or oncogene activation and 
acts hand- in-hand with apoptosis to limit tumorigenic expansion (27).  The discovery 
that cellular senescence is triggered by multiple activated oncogenes has led to the idea 
that senescence (like oncogene- induced apoptosis) is a critical and cell autonomous  
tumor preventative mechanism (26).  Additional evidence for cellular senescence acting 
as a barrier to cancer exists.  Most tumors contain cells that appear to have evaded 
senescence.  This extended replicative lifespan increases a cell’s susceptibility to 
malignant progression because it permits cell divisions that might acquire successive 
mutations.  Recently, it has been shown that senescence is not just a passive proliferation 
arrest that impacts only the senescent cell.  Instead, these cells influence their 
environment and neighboring cells through an active secretory system—producing 
different growth factors that stimulate the growth of neighboring cells.  For example, 
p21 expression in mammalian development has been localized to narrow zones of 





Figure 6.  DNA damaging reagents incite cellular response by activating ATM or ATR.  
These proteins can further activate a variety of additional regulatory proteins to result in 
cell cycle arrest at the G2/M phase of the cell cycle.  Other regulatory factors can affect 





Mechanism of Oncogene-Induced Senescence 
While many different oncogenes and growth regulatory molecules trigger 
senescence, the pathways that have been best described are for mutated oncogenic Ras 
and its effectors.  Chronic signaling through the Ras-Raf-MEK-ERK pathway drives 
senescence through activation of the p38 MAP-kinase-p16 stress response pathway (28, 
30).  There are multiple examples of oncogenes functioning as tumor-suppressors, 
resulting in oncogene- induced senescence (31-34).  
Oncogenic stress induces up-regulation of cyclin-dependent kinase inhibitor p16.  
High level expression of this protein activates Retinoblastoma (Rb), mitogenic signals, 
increases reactive oxygen species (ROS) and elicits a positive feedback of the ROS-
PKCσ signaling pathway (35).  In human somatic cells, once Rb is fully engaged, 
senescent cell cycle arrest becomes irreversible and cannot be revoked by subsequent 
inactivation of Rb and p53.  Interestingly, when Rb and p53 are inactivated, senescent 
cells reinitiate DNA synthesis, but they subsequently fail to complete the cell cycle, 
suggesting that these cells arrest in G2 or M phase (35). 
Additional evidence has shown that senescent cells acquire a specific gene 
expression profile or signature that includes the up-regulation of inflammatory 
cytokines.  This leads to the activation of the innate immune system which can clear a 








Role of p21 in Cellular Senescence 
When cells undergo DNA damage, this is accompanied by activation of p53.  
Additionally, the cyclin dependent kinase inhibitor CDKN1a (p21) can be activated in 
both a p53-dependent and –independent manner.  Induction of p21 is a common 
mechanism of growth arrest in cells under different physiological situations.  It is 
transiently induced in the course of replicative senescence, reversible and irreversible 
forms of damage- induced growth arrest, and in terminal differentiation of post-mitotic 
cells (11).  Within 14 hours after p21 induction, cessation of DNA replication and 
mitosis occurs—resulting in cells arresting not only in G1, but also in S and/or G2 phase.  
As Chang et al. showed, p21-9 cells (p21 is rapidly induced in these cells by addition of 
50 μM IPTG) showed morphological and senescence-associated β-galactosidase activity.  
This over-expression of p21 resulted in approximately equal numbers of cells arresting 
in G1 and G2 of the cell cycle through its interaction with and inhibition of CDKs.   
Additionally, p21 interaction with other genes can result in cell cycle arrest.  For 
example, p21 binds to c-Jun amino-terminal kinases and Gadd45 resulting in a p53-
independent G2 cell cycle arrest (36).   
The effects of p21 on cellular gene expression was investigated using cDNA 
arrays determining up- and down-regulated genes associated with over-expression of 
p21 in p21-9 cells.  Forty-three of the 69 down-regulated genes identified in the cDNA 
array were associated with cell cycle progression and DNA repair.  This indicated that 
the p21-mediated inhibition of gene expression and resulting senescence is highly 





matrix (ECM) components, ECM receptors and other secreted proteins.  Over-
expression of ECM proteins, including the p21- induced gene products fibronectin-1, 
plasminogen activator inhibitor 1 (PAI-I), tissue-type plasminogen activator (t-PA), and 
integrin β-3 are hallmarks of replicative senescence in normal fibroblasts (11). 
The reason p21 can induce cell cycle arrest (and ultimately senescence) at most 
stages of the cell cycle is due to its ability to operate in many different pathways (Figure 
7).  For example, induction of p21 in G1 results in inhibition of Cdk2, and an overall 
inhibition of the Cdk2/Cyclin E complex.  This inhibits phosphorylation of 
Retinoblastoma and cell cycle progression is halted.  Additionally, up-regulation of p21 
results in activation of p16, another cyclin dependent kinase inhibitor.  Activation of p16 
causes many cells to senesce in G1 phase of the cell cycle.  When cells are in S-phase 
and p21 is induced, the kinase activities of Cdk1 and Cdk2 are inhibited and this blocks 
the actions of the Cdk/Cyclin A complex.  These inhibitory effects result in cell cycle 
arrest and initiation of senescence in the S-phase of the cell cycle.  Finally, in G2 p21 
can either directly interact with Cdk1 to prevent Cdk1/Cyclin B from pushing the cell 
into mitosis, or it can interact with a variety of cell cycle regulatory proteins including 
14-3-3σ and Gadd45.  These regulatory proteins can also prevent the cell from moving 



















Figure 7.  Overview of cellular response to oncogenic stress.  This form of stress 
results in activation and up-regulation of p16, p53, and/or p21.  These proteins 







Figure 8.  Cyclin dependent kinase inhibitor p21 can effect cell cycle arrest at all 
stages of the cell cycle.  In G1 phase, p21 prevents phosphorylation of Rb, resulting in 
cell cycle arrest.  In S-phase, p21 can inhibit the kinase activity of cdk1 and cdk2 
which prevents the cell from moving into G2 phase.  Similarly, in G2 phase p21 





We have shown that Sim2s is down-regulated in human breast-cancer patients 
and breast cancer cell lines.  Re-establishment of Sim2s in highly invasive breast cancer 
cells results in loss of aggressive growth and metastasis.  Alternately, down-regulation of 
Sim2s in normal immortalized breast and non-invasive breast cancer cells results in an 
EMT and increased invasive potential.  Although these results suggest that Sim2s has 
breast tumor suppressor activity, the impact of Sim2s on cell cycle regulation has not 
been determined.  The studies here, we analyzed the impact of Sim2s over-expression in 







MATERIALS AND METHODS 
 
Cell Culture 
MCF7 cells were maintained in DMEM (Invitrogen, 11965118) supplemented 
with 10% fetal bovine serum (FBS, Atlanta Biologicals, S11550) and 5% penicillin-
streptomycin (Invitrogen 1514-0122).  HEK-293 cells were maintained in the same 
media as described above.  Cells were passaged at 70% confluency.    All MCF7 cells 
transduced by viral vectors were maintained in the same media, with an addition of 0.4 
μg/mL puromycin (Amresco J593-25mg).   
 
Lentiviral Transduction 
Lentiviral plasmids (pLPCX, Clontech, Sold as part of Catalog # 631511) (Figure 
9) were transfected into HEK293 cells, stably expressing Amphotrophic envelope 
proteins, referred to as Ampho 293 cells.  Thirty microliters of GeneJuice (Novagen 
70967) was added to one milliliter of OptiMEM (Invitrogen, 31985062) and allowed to 
incubate at room temperature for 5 minutes.  Ten micrograms of DNA (a 3:1 ratio of 
GeneJuice to DNA was used) was added, vortexed, and allowed to incubate at room 
temperature for 15 minutes.  This mixture was added to 10 cm plates of Ampho 293 cells 
at about 75-80% confluency.  Media was changed 24 hours later and the cells were then 
transferred from 37°C to 32°C.  Media was collected at 48 and 72 hours post 





and polybrene was added to a final concentration of 4 μg/mL.  Viral media was then 
added to target cells.  The target cells were also incubated at 32°C while undergoing 
viral infection to promote viral stability.  After the infection period was finished, fresh 
media was added and the cells were returned to 37°C.  Selection using puromycin was 
started 24 hours later.  A previous kill curve allowed us to determine the optimal 







Figure 9.  pLPCX vector map.  The pLPCX vector was obtained from Clontech.  Sim2s 






RNA Isolation from Cells 
Cells were grown to 50-70% confluency, washed with 1xPBS and harvested for 
RNA using the High Pure RNA Isolation kit (Roche, 11828665001) following the 
Isolation of Total RNA from Cultured Cells protocol.  RNA was eluted in 50 μL of 
elution buffer and stored at -80°C.  
Reverse Transcription 
Depending on the RNA concentration, 0.5-2 μg of RNA was used for reverse 
transcription reactions.  The Transcriptor First Strand cDNA Synthesis kit (Roche, 
04379012001) was used.  One microliter of Anchored Oligo dT and 2 μL of Random 
hex primers were added to RNA in H2O for a total of 13 μL.  The sample was incubated 
at 65°C for 10 minutes, then held at 4°C while 4 μL of TRT 5x Buffer, 0.5 μL RNase 
inhibitor, 2 μL Deoxy Mix, and 0.5 μL Reverse Transcriptase was added to each sample.  
Samples went through the following thermocycler program:  25°C for 10 minutes, 50°C 
for 60 minutes, 85°C for 5 minutes, with a 4°C hold at the end.  cDNA was diluted to 
20-25 ng/μL with H2O and stored at   -20°C for long term, and 4°C for immediate use.  
Real Time PCR 
The following mixture was added to each well of a 96 well plate (Applied 
Biosystems MicroAmp N801-0560): 20.5 μL of SYBR [FastStart Universal SYBR 
Green Master (Rox) (Roche, 04913850001)], 2.0 μL cDNA, and 2.5 μL primer mix.  
Reactions were run according to the following cycle conditions:  95°C for 10 minutes, 





performed using the ΔΔCT method.  Human TATA-binding protein (TPB) was used to 
normalize levels of assayed genes.  Primer sequences can be found in Table 1.  
 
 
Gene Name Sense (5’3’) Antisense (5’3’) 
14-3-3δ CAA AGA CAG CAC CCT CAT CAT G CTC TTC CCC GGC GTT GT 
CyclinD1 TGG GTC TGT GCA TTT CTG GTT GCT GGA AAC ATG CCG GTT AC 
E-cadherin CAC AGA CGC GGA CGA TGA T GAT CTT GGC TGA GGA TGG TGT AA 
FN1 CCA AGA AGG GCT CGT GTG A GGC TGG AAC GGC ATC AAC 
Gadd45 CAA CGA GGA CGC CTG GAA CGG CTC TCC TCG CAA AAC 
GSK-3β CTC ATG CTC GGA TTC AAG CA CAC GGT CTC CAG TAT TAG CAT CTG 
MMP1 CCT CGC TGG GAG CAA ACA TTG GCA AAT CTG GCG TGT ACA 
NOXA CTG CAG GAC TGT TCG TGT TCA GGA ACC TCA GCC TCC AAC TG 
p21 CCT AAT CCG CCC ACA GGA A AAG ATG TAG AGC GGG CCT TTG 
p27 GCT AAC TCT GAG GAC ACG CAT TT CGC ATT GCT CCG CTA ACC 
p53 TCT TTG AAC CCT TGC TTG CA CCG GGA CAA AGC AAA TGG 
PUMA GGG CCC AGA CTG TGA ATC CT CGT CGC TCT CTC TAA ACC TAT GC 
SERBP1 ACG CCT TCA TCT GGG ACA AA CTA AAA TTC TTT TCT TCG GAG TTT CTT 
Sim2s  AAG GTG GGC GGA TCA CCT CAG CTT CTT GGC AGG CTT G 
TBP TGC ACA GGA GCC AAG AGT GAA CAC ATC ACA GCT CCC CAC CA 
 
Note:  All primers were designed based on mRNA reference from NCBI using Primer 











Chromatin Immunoprecipitation Assay (ChIP) 
Chromatin Harvest 
Formaldehyde (Sigma F1635) was added to a final concentration of 1% to fresh 
culture media.  Cells were incubated in this media at room temperature for 10 minutes 
with gentle rocking.  To stop crosslinking, glycine (Sigma G8898) was added to a final 
concentration of 125 mM and then rocked at room temperature for an additional five 
minutes.  Cells were then washed in ice-cold 1x PBS twice and then scraped in cold PBS 
containing 25x Complete protease inhibitors (CPI Roche 11-697-498-001) and 
phosphatase inhibitors [0.05M sodium orthovanadate (Sigma, S6508), 0.25 M sodium 
molybdate (Aldrich, 243655), 0.5 M sodium fluoride (Sigma, S6776)].  To pellet the 
cells, they were spun at 805xg for 4 minutes using an Eppendorf 5810R centrifuge 
chilled to 4°C.  To resuspend cells, Nuclear Lysis buffer was added (50 mM Tris pH 8.1, 
10 mM EDTA, 1% SDS, 25x Complete protease inhibitors) and then the cells were 
incubated on ice for 10 minutes.  DNA was sheared in 10 second pulses, 10 times, with a 
one minute pause on wet ice to allow the cells to cool after every 2 pulses.  To pellet the 
cellular debris, the cellular lysate was spun at 16,100 x g in an Eppendorf 5415D 
centrifuge for 10 minutes at 4°C.  Chromatin was stored at -80°C in 60 μL aliquots. 
Standard ChIP Assay 
ChIP dilution buffer (0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA, 16.7 mM 
Tris pH 8.1, 167 mM NaCl, 25x Complete protease inhibitors) was added to one aliquot 
of chromatin to dilute it 5- fold.  To pre-clear the samples 80 μL of salmon sperm 





4°C for 30 minutes.  Beads were pelleted by spinning at 200 x g for 1 minute in an 
Eppendorf centrifuge.  This step was repeated to complete the pre-clearing.  Ten percent 
of the sample was saved back for input control while the remainder of the sample was 
split for addition of an antibody and a no antibody control.   
The following day, 60 μL of agarose beads were added for 1 hour at 4°C with 
rocking.  Samples were spun at 2000 x g for 1 minute and supernatant was removed.  
Beads were washed consecutively for 10 minutes in each solution:  Low Salt Wash 
(0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris pH 8.1, and 150 mM NaCl), 
High Salt Wash (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris pH 8.0 and 
500 mM NaCl), Lithium Chloride Wash (0.25 M LiCl, 1% NP-40, 1% sodium 
deoxycholate, 1 mM EDTA, and 10 mM Tris pH 8.0) and twice in TE buffer (10 mM 
Tris pH 8.0 and 1 mM EDTA).  All washes were completed at 4°C except for the TE 
washes, which were done at room temperature.  Immune complexes were eluted from 
the beads by the addition of 250 μL Elution buffer (1% SDS and 0.1 M NaHCO3) 
vortexing, rocking at room temperature for 15 minutes, then spinning at 14,000 x g for 3 
minutes in an Eppendorf centrifuge.  Supernatant was removed to a fresh tube, and the 
process was repeated on the beads for a final volume of elute of 500 μL.  NaCl was then 
added to a concentration of 0.3 M with 1 μL of 10 mg/mL RNAse-A.  Elutes were then 
incubated at 65°C for 4-5 hours to reverse formaldehyde cross- links.  To precipitate the 
DNA, 2.5 volumes of 100% ethanol was added to each sample and they were placed at -
20°C overnight.  On the third day, DNA was pelleted by spinning at 14,000 x g in an 





resuspended in 100 μL H2O.  To each sample the following were added:  2 μL 0.5 M 
EDTA, 4 μL Tris, pH 6.5, and 1 μL 20 mg/mL Proteinase K (Sigma 93161722).  
Samples were incubated at 45°C for 1 hour, then purified using a Qiagen PCR 
purification kit (Qiagen 28106).  DNA was eluted in 50 μL elution buffer (supplied in 
kit).  PCR was performed according to conditions listed in Table 2.  
 
 
Target Strand Sequence Anneal °C 
5’ Region of p21 
Sense CCAGGTCTTGGATTGAGGAA 50 
Antisense TGTTAAGGTGGTGGCATTGA 50 
p53 Response 
Element of p21 
Sense ACATTGTTCCCAGCACTTCC 50 
Antisense ACACAAGCACACATGCATCA 50 
TATA region of 
p21 
Sense TCTAGGTGCTCCAGGTGCTT 50 
Antisense ACATTTCCCCACGAAGTGAG 50 
Exon 3 Start site of 
p21 
Sense GTCCGTCAGAACCCATGC 50 
Antisense CAGGTCCACATGGTCTTCCT 50 
Stop region of p21 
Sense CCAAGAGGAAGCCCTAATCC 50 
Antisense ACAAGTGGGGAGGAGGAAGT 50 
 
 
Western Blot Assay 
Protein Isolation 
Cells were washed once with ice-cold 1X PBS and scraped in 2 mL 1X PBS.  
Cells were pelleted by spinning at 2000 x g for 4 minutes in an Eppendorf centrifuge.  
Supernatant was removed and Lysis buffer [20 mM Tris-Cl pH 8.0, 137 mM NaCl, 10% 





glycerol, 1% NP-40, 2 mM EDTA, 25x protease inhibitors, and phosphatase inhibitors 
was added to resuspend cells.  Cells were agitated at 4°C for 30 minutes.  Debris was 
pelleted by spinning in a cooled Eppendorf centrifuge at 14,000 x g for 10 minutes.  
Aliquots were stored at -20°C, unless they were to be used immediately, in which case 
they were stored at 4°C.  An RC/DC Protein Assay kit (BioRad 500-0120) was used to 
ascertain protein concentration. 
Standard Analysis 
After determining the amount of protein to add for a certain concentration, 
samples were QS’d to 30 μL with H2O and 6 μL of 6x SDS loading buffer (60% 
glycerol, 0.3 M Tris pH 6.8, 12 mM EDTA, 12% SDS, 6% β-mercaptoethanol, 0.5% 
bromophenol blue) was added and samples were boiled for 5 minutes, followed by 5-10 
minute incubation on wet ice.  Acrylamide gels ranging from 8-12% were cast for 
analysis.  Gels were run at 110 mV (constant V) for 1-2 hours and transferred to PVDF 
membranes for 2 hours at 110 mA (constant mA).  Depending on antibody conditions 
membranes were blocked in either PBS-T + 5% milk (BioRad 170-6404) or TBS-T + 
5% milk.  All primary antibodies were incubated at 4°C over night, while gently rocking.  
See Table 3 for antibody sources and incubation conditions.  Proteins were visualized 
with the Amersham ECL Plus western blotting detection reagent (GE Healthcare RPN 
2132) on film (HyBlot CL Autoradiography film, Denville Scientific, L3018).  Films 
were developed on a Kodak M35a X-omat film processor.  All films were scanned using 







Cells were plated in six-well plates two to three days prior to use.  Cells to be 
treated with UV or sham were treated, and then six hours later stained for β-
galactosidase [Senescence beta-Galactosidase Staining kit (Cell Signaling, 9860)].  The 
cells were washed with 1X PBS twice; then treated with the 1X Fixative solution for 15 
minutes at room temperature.  After incubation, cells were washed with 1X PBS twice, 
and then treated with the 1X Staining solution as described in the kit protocol.  The 
Staining solution was equilibrated to pH 6.0 and the cells were incubated at 37°C 
overnight in a ProBlot 6 Hyb oven.  Cells were imaged on SteREO Discovery.V12 
microscope at various magnifications.  
 
Clonogenic Survival Assay 
Plating Cells 
To plate equal numbers of cells, cellular media was removed, cells were rinsed 
with 5 mL 1X PBS, and 2 mL 0.5% trypsin-EDTA was added.  Cells were re-suspended 
in 8 mL media to neutralize trypsin.  Cells were vigorously pippetted to break up 
clumps, then 100 μL of this solution was added to 20 mL isotonic solution to be counted 
on a Beckman Coulter Z1 Coulter Particle Counter.  Cells were plated at 5000 cells/well 
in a 6-well plate.  Cells were allowed to settle and adhere to the plate for 2 hours, at 
which point they were treated with 2000 μJ/m2 UV.  Cells were incubated at 37°C for 6 





Antibody Company/Cat. # Dilution Amt. protein Washes/Milk Secondary Company/Cat. # Dilution 
Rb α ACH3 Millipore/06-599  (1:2000) 10 0.1% TBS-T/TBS-T 5% milk Dk α Rb Santa Cruz/sc-2313 (1:5000) 
Ms α B-Actin  Sigma/A5441 (1:7000) 10 0.05% PBS-T/PBS-T 5% milk IgG α Ms Upstate/12-349  (1:4000) 
Rb α cdc2  Millipore/15-120 (1:1000) 50 See product information Dk α Rb Santa Cruz/sc-2313 (1:5000) 
Rb P-cdc2 Santa Cruz/12340-R (1:500) 50 0.1% TBS-T/TBS-T 5% milk Dk α Rb Santa Cruz/sc-2313 (1:4000) 
Rb α cdc25A  Santa Cruz (1:500) 150 0.1% TBS-T/TBS-T 5% milk Dk α Rb Santa Cruz/sc-2313 (1:5000) 
Rb α Cyclin A Santa Cruz/sc-596 (1:800) 50 0.1% TBS-T/TBS-T 5% milk Dk α Rb Santa Cruz/sc-2313 (1:5000) 
Ms α Cyclin B1 Millipore/15-120 (1:1000) 50 See product information IgG α Ms Upstate/12-349  (1:4000) 
Rb α Cyclin E Neomarkers/RB-012-PO (1:1000) 50 0.1% TBS-T/TBS-T 5% milk Dk α Rb Santa Cruz/sc-2313 (1:5000) 
Rb α cleaved caspase 9 Cell Signaling/9501 (1:500) 75 0.1% TBS-T/TBS-T 5% milk Dk α Rb Santa Cruz/sc-2313 (1:5000) 
Rb α Gadd45α Santa Cruz/SC-797 (1:500) 10 0.05% PBS-T/PBS-T 5% milk Dk α Rb Santa Cruz/sc-2313 (1:5000) 
Rb α GSK3B Cell Signaling/9323 (1:1000) 150 0.05% PBS-T/PBS-T 5% milk Dk α Rb Santa Cruz/sc-2313 (1:5000) 
Ms α H3K9Me2 AbCam/ab1220 (1:500) 75  0.05% PBS-T/PBS-T 5% milk IgG α Ms Upstate/12-349   (1:4000) 
Ms α Hsp90 Stressgen/SPA-830 (1:500) 50 0.1% TBS-T/TBS-T 5% milk IgG α Ms Upstate/12-349   (1:5000) 
Rb α Ki67 Neomarkers/RM-9106 (1:500) 50 0.05% PBS-T/PBS-T 5% milk Dk α Rb Santa Cruz/sc-2313 (1:5000) 
Ms α p21 Dako Cytomation/9286 (1:700) 150 0.05% PBS-T/PBS-T 5% milk IgG α Ms Upstate/12-349   (1:4000) 
Gt α p53 R&D/1355 (1:1000) 10 0.1% TBS-T/TBS-T 5% milk Dk α Gt Santa Cruz/sc-2033 (1:4000) 
Rb α P-p53 Cell Signaling/9286 (1:1000) 100 0.05% PBS-T/PBS-T 5% milk Dk α Rb Santa Cruz/sc-2313 (1:5000) 
Rb α PARP Cell Signaling/9541 (1:1000) 50 0.1% TBS-T/TBS-T 5% milk supplied in kit 
 
  
Rb α Retinoblastoma Santa Cruz/sc-50 (1:500) 150 0.1% TBS-T/TBS-T 5% milk Dk α Rb Santa Cruz/sc-2313 (1:5000) 
Rb α Sim2s Millipore/AB4145 (1:700) 150 0.05% PBS-T/PBS-T 5% milk Dk α Rb Santa Cruz/sc-2313 (1:5000) 






Fixing and Staining Cells 
The cell media was removed and cells were rinsed with 1X PBS.  Two millileters 
of 3.0% gluteraldehyde and 0.5% crystal violet was added to each well of the six-well 
plates and plates were incubated for 60 minutes at room temperature.  The 
gluteraldehyde/crystal violet mixture was removed from each well and plates were 
carefully rinsed by immersing in a sink filled with room temperature tap water.  Plates 
were turned upside down and allowed to dry at room temperature over-night.   
Analysis 
ImageJ 1.42q was used to analyze stained cells.  After tak ing pictures of the cells 
on a SteREO Discovery.V12 microscope, images were opened in Image J.  
ProcessBinaryMake Binary edited the pictures to black and white.  
AnalyzeAnalyze particles allowed the program to count individual cells.  Pixel size 
had to be adjusted to the smallest size allowable for the program to count, this number 
was maintained for all images counted at the same magnification.  
 
Proliferation Assay 
Cells were counted as mentioned above and then plated 5000/well into the wells 
of 6-well plates.  Cells were counted from one well each day for 7 days.  The count was 










Falcon tubes (15 mL) were filled with 4.5 mL of ice-cold 70% EtOH and kept on 
ice.  Cells were harvested at 75-80% confluency using 0.5% Trypsin-EDTA.  Cells were 
centrifuged at 250xg for 3 minutes, the supernatant was removed, and the cells were 
resuspended in 500 μL 1X PBS.  The resuspended cells were vortexed vigorously to 
break up any cell clumps, and transferred to the chilled tubes of 70% EtOH and vortexed 
vigorously again.  Cells were stored at -20°C until use. 
Staining Cells 
Because MCF7 cells break down and clump so easily, a propidium idodide (PI) 
solution containing no detergent was optimized.  A hypotonic solution containing 
sodium citrate allowed the propidium idodide to incorporate into the nucleus without 
over-damaging cells.  The stock solutions used to create the PI solution are as follows:  
Sodium citrate (11.76 mg/mL), Propidium idodide (1.0 mg/mL), RNaseA (2.0 mg/mL).  
The final concentrations required in the PI solution are as follows:  Sodium Citrate (4 
mM), PI (50 μg/mL), RNaseA (200 μg/mL). 
Preserved cells in 70% EtOH were spun down at 500xg for five minutes, and the 
supernatant was removed.  Cells were rinsed in 1X PBS, allowed to rest for 60 seconds, 
then spun at 500xg for five minutes.  The supernatant was removed again and the cells 
were resuspended in one millileter of the PI solution.  Cells were vortexed vigorously to 
prevent clumping, and incubated at RT for 20 minutes.  Cells were then placed on ice 






Cells were run on a FACSCalibur (Becton Dickinson Immunocytometry 
Systems) and then analyzed using ModFit LT, version 3.2 for Macintosh (Verity 
Software House, Topsham, MA). 
 
DIC Imaging 
Differential interference contrast images of MCF7 pLPCX-Sim2s and –Empty 
cells were captured with a Zeiss Stallion Dual Detector Imaging System with Intelligent 
Imaging Innovations Software (Carl Zeiss Inc., Thornwood, NY).   
 
Statistical Analysis 
 Results referred to in the remaining text are expressed as mean ± SEM.  Data 







THE ROLE OF SIM2S IN CELL CYCLE REGULATION 
 
 
Our laboratory has previously shown that over-expression of Sim2s in MDA-
MB-435 cells results in decreased proliferative and invasive potential of this normally 
highly invasive breast cancer cell line.  Additionally, when Sim2s is knocked down in 
the less invasive MCF7 breast cancer cell line it increases their invasive and proliferative 
potential and creates an EMT-like phenotype (18). 
To further investigate the role of Sim2s as a tumor suppressor, we over-expressed 
Sim2s in MCF7 cells using a lentiviral system.  Similar to the MB-MDA-435 cells, we 
found that Sim2s decreased cell proliferation (Figure 10).   
Because of this decreased proliferation we investigated the possibility that these 
cells were arresting at a particular stage of the cell cycle by performing propidium 
idodide flow cytometry.  The results show that there is significant accumulation of cells 
in G2/M and S phases of the cell cycle in MCF7-Sim2s cells compared to Empty 
controls (Figure 11).  Western blot analysis of the cyclins and CDKs involved at these 
cycle checkpoints found no differences in expression levels (Figure 12).   
Because we observed no differences at this level, we looked at RNA expression 
levels of regulatory factors involved in monitoring cell cycle regulation.  We surveyed 
several regulatory proteins involved in arrest at G2/M including 14-3-3δ, GSK3-β, and 
GADD45.  While there was no change in 14-3-3σ or GSK3-β, GADD45 mRNA was up-
regulated.  However, Western blot analysis showed no up-regulation at the protein level 





involved in regulating cell cycle arrest at the G1 stage) and found no change in 
expression of this gene. 
Figure 10.  Proliferation assay on MCF7 pLPCX-Empty and Sim2s cells.  










Figure 11.  Propidium iodide flow cytometry of MCF7 pLPCX Empty and Sim2s 
cells.  Significantly more Sim2s over-expressing MCF7 cells are found in the G2/M 
and S phases of the cell cycle.  Columns represent mean recorded cells, (n=18); bars, 










 Figure 12.  Western blot analysis of major cyclins and CDKs involved in cell cycle.  
Because MCF7 cells over-expressing Sim2s arrest in G2/M and S phase, cyclins and 
CDKs involved in these phases of the cell cycle were surveyed.  Equal amounts of 
protein were loaded and subjected to immunoblotting.  There was no discernable 
change in expression levels of any of these cell cycle proteins between Empty and 












Figure 13.  Real Time PCR assay of expression levels of regulatory protein RNA 
levels and Western blot analysis of GADD45.  A. Cell cycle regulatory proteins from 
the G2/M phase of the cell cycle were surveyed to investigate if up-regulation of Sim2s 
resulted in concomitant up-regulation of these proteins.  Only GADD45 showed 
significant up-regulation with over-expression of Sim2s, but was not up-regulated at 
the protein level.  As a control, p27, a regulatory protein involved in G1 arrest was 
surveyed.  No change was noted between Sim2s and Empty controls.  B.  Western blot 
analysis of Gadd45 showed no change between Empty and Sim2s.  For all Real Time 
PCR analyses, expression levels are relative to TBP expression, (n=3); bars, SEM; *, 
P<0.05.  For Western blot analysis, equal amounts of protein were loaded and 







THE ROLE OF SIM2S IN DNA DAMAGE RESPONSE AND CELLULAR 
SENESCENCE 
 
In addition to being closely linked with the G1 checkpoint, p21 is also involved 
in regulating several other checkpoints in the cell cycle, including the G2/M and S 
phases.  To determine if the G2/M arrest observed in MCF7 cells over-expressing Sim2s 
is associated with changes in p21, we analyzed p21 expression levels.  The results show 
that over-expression of Sim2s significantly increased p21 basal levels at both the RNA 
and protein levels, suggesting that the G2/M arrest may be p21 dependent (Figure 14). 
Previous studies have shown that down-regulation of Sim2s in MCF7 cells by 
shRNA (Sim2si) induces an EMT characterized by increased proliferation and invasion 
both in vitro and in vivo (18).  Analysis of p21 expression in control and Sim2si MCF7 
cells showed that loss of Sim2s corresponds to a decrease in basal p21 expression at the 
RNA and protein levels (Figure 15). This trend is also observed in response to DNA 
damage in the form of doxorubicin exposure: Scr cells show a significant increase in 
p21, while Sim2si show little response.  In contrast, exposing Empty and Sim2s cells to 
UV radiation dramatically increases p21 expression.   
In addition to p21, changes in p53 levels were investigated to ascertain whether 
the differences in p21 expression required activation of p53.  When Sim2s is knocked-
down in MCF7 cells, p53 protein (but not RNA) levels increase dramatically, regardless 





increase upon exposure to DNA damage, the change is no different from that of Empty 
control cells.  There is no dramatic difference in phospho-p53 levels with Sim2s over-
expression, suggesting that the up-regulation of p21 by Sim2s is p53- independent 
(Figure 15).   
 
A 
Figure 14.  Real Time PCR assay and Western blot analysis of p21.  A.  Expression 
levels of p21 were also analyzed and found to be significantly up-regulated in Sim2s 
cells at both the RNA and protein levels.  B.  Real Time PCR analysis, expression 
levels are relative to TBP expression, (n=3); bars, SEM; *, P<0.05.  Western blot 


















Figure 15.  Over-expression of Sim2s regulates p21 expression in response to DNA 
damage.  A.  MCF7 cells over-expressing Sim2s have significantly higher p21 RNA 
levels than Empty control cells.  This trend continues with exposure to 5000uJ/m2 UV.  
B.  Previous work in our laboratory has shown that knock-down of Sim2s results in 
almost complete ablation of p21 RNA expression.  C.  In MCF7 cells that have had 
Sim2s over-expressed, protein expression of p21 is greater, regardless of both exposure 
to DNA damage, and phospho-p53 levels as compared to Empty control cells.  D.  
Western blot confirms that p21 expression is not seen in Sim2si cells, even though 
there is increased p53 expression.  UV=5000 μJ/m2, Sham=sham irradiation, 
VH=DMSO, DOX=treatment with 1 μM doxorubicin for 12 hours.  For all Real Time 
PCR analyses, expression levels are relative to TBP expression, (n=3); bars, SEM; *, 
P<0.05.  For Western blot analysis, equal amounts of protein were loaded and 






Our lab previously demonstrated that basal and DNA damage induced p21 
expression is Sim2s dependent (Figure 15).  Because p21 plays such a major role in 
response to genotoxic stress, we exposed MCF7 Empty control and Sim2s cells to 
1000μJ UV and measured changes in proliferation using a clonogenicity assay.  As 
expected, MCF7-Sim2s cells grew at a slower rate compared to controls and this 
response was further exacerbated in response to UV irradiation (Figure 16). 
This loss of clongenicity has been shown previously with up-regulation of p21.  
Chang et al. showed that over-expression of p21 from an inducible promoter resulted in 
a senescent- like growth arrest in a human fibrosarcoma cell line.  After release from this 
growth-arrest, cells re-entered the cell cycle but showed growth retardation, cell death, 
and decreased clonogenicity (37). 
Because Sim2s is a transcription factor we performed a Chromatin 
Immunoprecipitation (ChIP) assay to determine if Sim2s binds the p21 gene.  Chromatin 
was harvested from WT MCF7 cells treated with either 5000 μJ UV or sham and pulled 
down using a Sim2s antibody.  Using primers located across the p21 gene we looked to 
see if Sim2s was bound at any of the locations (5’ region of the gene, p53 Response 
element, TATA region, ATG start of exon 3, or the Stop region) surveyed.  In response 
to UV radiation, Sim2s binds to p21 at the 5’ region of p21, the p53 Response element, 






Figure 16.  Clonogenic survival assay of MCF7 pLPCX-Empty and Sim2s cells to 
ascertain survival upon exposure to genotoxic stress.  A.  Crystal violet staining.  The 
same number of cells was plated for both Sim2s and Empty controls and then treated 
with 1000μJ UV.  After seven days, cells were fixed, and stained with crystal violet.  
B. Cells were analyzed using ImageJ to determine how many cells had survived the 
initial genotoxic stress.  Sim2s cells are less proliferative overall, but appear to be 








Figure 17.  ChIP analysis of MCF7 pLPCX-Empty and Sim2s cells upon exposure to 
UV radiation.  Because p21 is often up-regulated in response to DNA damage, MCF7 
cells were treated with 5000μJ/m2 UV.  ChIP assay shows that Sim2s binds to the p21 
gene at the 5’ region, p53 Response Element, and to a small extent at the ATG start 






 In addition to arresting cells at various stages of the cell cycle, p21 also plays an 
important role in promoting cellular senescence.  Because of the significant inhibition of 
proliferation observed in Sim2s over-expressing cells, we needed to determine if the 
cells were not only arresting, but actually undergoing cellular senescence.  Our initial 
observations of morphological differences showed that Sim2s over-expressing cells had 
the characteristic ―fried-egg‖ appearance of senescent cells (Figure 18).   
Additionally, we performed a β-galactosidase stain to confirm senescence and the 
increased β-galactosidase activity observed in the Sim2s cells is a positive indication of 
senescence (Figure 19).  To further confirm the senescence phenotype, we analyzed 
changes in Ki67, a nuclear marker highly expressed in actively proliferating cells, but in 
lower levels in cells undergoing senescence; and H3K9Me2, a histone marker often 
found in higher quantities in sesescent cells, but not in cells actively proliferating.  
Western blot analysis shows that Sim2s cells had decreased levels of Ki67 and an 
increase in H3K9Me2 levels—further confirming that these cells are undergoing 
senescence   (Figure 20).  Additionally, we found that Sim2s cells increased levels of 









Figure 18.  DIC images of Sim2s over-expressing MCF7 cells and Empty controls.  








Figure 19.  MCF7 pLPCX-Sim2s cells have increased β-galactosidase staining as 
compared to Empty controls.  This is seen with no treatment (top two panels), sham 
treatment (middle two panels), and 5000μJ UV treatment (bottom two panels).  This 











Figure 20.  Western blot analysis of cell proliferation marker Ki67 and apoptotic 
marker PARP.  A.  Empty cells have higher levels of the nuclear marker Ki67 
indicating a higher level of proliferative activity as compared to Sim2s cells.  PARP 
levels are higher in Sim2s cells however, indicating that these cells are also 
undergoing increased apoptosis—in addition to their increased cellular senescence.  B.  
A different Western blot shows the histone marker H3K9Me2, generally associated 
with decreased activity (decreased proliferation) is seen to be up-regulated in MCF7 
cells over-expressing Sim2s.  Equal amounts of protein were loaded and subjected to 
immunoblotting.  Results shown are representative from two trials in A, but only one 








In Drosophila, the Singleminded gene is responsible for cell fate determination in 
central nervous development and during embryogenesis (3, 38).  Because of its location 
in the Down Syndrome Critical Region of Chromosome 21 and the decreased incidence 
of breast cancer seen in these individuals, our laboratory was interested in determining 
the role Sim2 plays in breast cancer.  We were the first to determine the role of the short 
isoform of Sim2, Sim2s, in normal development of the mammary gland and the 
requirement of Sim2s in maintaining epithelial cell fate in breast cancer cells (18).  
Additionally, we have shown that precocious expression of Sim2s in vivo promotes an 
alveolar epithelial cell phenotype with an increase in a subset of milk protein genes (9).  
Based on these studies, we hypothesized that Sim2s has tumor suppressive activity and 
that over-expression of Sim2s in MCF7 cells will result in cell cycle arrest and 
sensitization to DNA damaging reagents.  
 To test this hypothesis, we used a lentiviral vector to over-express Sim2s in 
MCF7 cells.  We have previously reported that over-expression of Sim2s in MDA-MB-
435 cells resulted in decreased proliferation.  This was also observed with over-
expression of Sim2s in MCF7 cells (Figure 9).  To determine if this decreased 
proliferation is the result of a cell cycle arrest, propidium iodide flow cytometry was 
performed and significantly more Sim2s over-expressing cells were found in G2/M and 





for Sim2s over-expressing cells and Empty controls we found that there were no changes 
in expression of critical cell cycle regulations (Figure 11) which led us to conclude that 
Sim2s is not causing cell cycle arrest by directly influencing expression levels of the 
cyclins and CDKs involved in S and G2/M phase (cyclin A, E and B1 and CDK1).  
However, to fully determine if this is the case, a survey of phosphorylated cyclins and 
CDK or a kinase activity assay should be done.   
Before examining this further, we investigated whether Sim2s over-expression 
influenced expression of regulatory proteins.  The key regulatory G2/M proteins 14-3-3σ 
and GADD45α play roles in influencing a G2/M arrest (39).  Upon activation, 14-3-3σ 
binds to Cdc25c, sequestering it in the cytoplasm, thus inhibiting subsequent binding to 
Cdc2, ultimately preventing the cell from moving through G2 into M phase.  Activation 
of GADD45α causes cell cycle arrest at the G2/M phase by directly interacting with 
Cdc2 and causing it to dissociate from Cyclin B.  Additionally, GADD45α can directly 
interact with p21, inducing cell cycle arrest via p21 interaction with cell cycle proteins.  
Because all of these regulatory proteins work by merely causing dissociation, but not 
down-regulation of the cell cycle proteins, we hypothesized that the effects of Sim2s on 
cell cycle arrest was due to interaction with one or more of these regulatory proteins.  
We surveyed mRNA levels of these three major regulatory proteins and found no 
difference in expression between MCF7 Empty control and Sim2s cells, suggesting that 
other pathways are required to mediate Sim2s-dependent cell cycle arrest.  However, to 
truly ascertain differences in expression, since G2 arrest is caused by protein activation, 





regulatory proteins will need to be done.  GADD45α was analyzed via Western blot, and 
no significant difference in protein levels between Sim2s and control cells was observed.  
The cyclin-dependent kinase inhibitor p21 plays an essential role in DNA 
damage response, by inducing cell cycle arrest, inhibiting DNA replication and by 
regulating key apoptotic processes.  The ability of p21 to interact with a number of 
proteins involved in these processes is extremely important.  We found that over-
expression of Sim2s results in up-regulation of p21 and we hypothesize that either 
individually, or in direct interaction with p21 results in the observed G2/M cell cycle 
arrest.  However, to investigate this hypothesis we will need to perform a CoIP and/or 
ChIP to show interaction between p21 and Sim2s. 
In contrast to the up-regulation of p21 observed with over-expression of Sim2s in 
MCF7 cells, previous work in our lab has shown that in cells that have had Sim2s 
knocked down (Sim2si cells), p21 expression is ablated—even in response to DNA 
damage, which is usually a strong stimulus for p21 activation (40) (Figure 13).  Because 
DNA damage usually results in p53 activation, we were interested in determining p53 
expression in the case of Sim2s knock-down and over-expression.   
In Sim2si cells levels of p53 increased regardless of DNA damage (UV 
radiation).  However, this was not accompanied with increased p21 expression.  In 
contrast, in the Sim2s over-expressing cells, p53 levels only increased in response to 
DNA damage, whereas p21 levels were significantly higher in all cells over-expressing 
Sim2s (Figure 15).  In both cases, the p21 response appears to be p53- independent.  The 





that Sim2s could play a role in activating or interacting with p53 in addition to p21.  
Because of the role p53 and p21 both play in cellular response to DNA damage through 
arrest or apoptosis, it is important to further delineate the mechanism through which 
Sim2s affects the observed cellular senescence.   
 To investigate if over-expression of Sim2s and the resulting up-regulation of p21 
affected cells viability, we exposed MCF7 cells to UV radiation.  We hypothesized that 
Sim2s-mediated up-regulation of p21 would result in sensitization to genotoxic reagents 
and thus a decrease in cell proliferation/survivability.  After exposure to 1000 μJ of 
radiation, cells were grown for one week and stained to assay clonogenicity.  In support 
of our hypothesis, Sim2s over-expressing cells were indeed sensitized to DNA damage 
(Figure 14).  This result was interesting because of the role p21 plays in ce ll cycle arrest.  
To investigate this process further we wanted to determine if p21 was playing a role in 
inducing cellular senescence and causing the observed cell cycle arrest.  First, however, 
we performed a ChIP analysis to determine if Sim2s can interact with p21.  Using five 
sets of primers spread across the p21 gene, we assayed for Sim2s binding in normal 
MCF7 cells.  We found that Sim2s does bind to p21at the 5’ region of the gene, TATA 
box region, and at the ATG start of Exon 3 (Figure 15).  This observation was only 
detected when cells had been exposed to DNA damage (UV radiation).  This suggests 
that Sim2s can bind the p21 promoter and potentially induce activation of this gene in 
response to DNA damage resulting in the observed cell cycle arrest. 
 The observed cell cycle arrest was further investigated to determine if the cells 





This confirmed what was observed under less magnification: cells over-expressing 
Sim2s are larger with frilled edges—resembling the ―fried-egg‖ appearance 
characteristic of senescent cells (Figure 16).  To confirm senescence we performed 
several different assays.  Sim2s over-expressing cells and Empty controls were stained 
for β-galactosidase activity and a significant increase in this activity (indicative of 
cellular senescence) was noted in Sim2s over-expressing cells (Figure 17).  Other 
markers that are indicative of a senescence status were also evaluated.  Ki67 (a nuclear 
antigen found in actively proliferating cells) expression is found in higher levels in 
Empty controls as compared to Sim2s over-expressing cells.  Additionally, we looked at 
the histone marker H3K9Me2 which is generally associated with a closed conformation, 
indicative of decreased transcriptional activity and cell proliferation.  Western blot 
analysis shows that Sim2s over-expressing cells have increased levels of this repressive 
histone marker, compared to Empty controls (Figure 18).  Based on these assays, we 
concluded that Sim2s cells are indeed undergoing senescence; most likely due to the up-
regulation of p21 as a result of over-expression of Sim2s.  In addition to induction of 
cellular senescence, we observed an increase in cleaved PARP expression in Sim2s over-
expressing cells.  Due to this up-regulation, we conclude that not only are these cells 
undergoing senescence, but are also undergoing increased apoptosis—which is perhaps 
indicative of their increased sensitivity to DNA damaging reagents.  The increased 
observed cellular senescence is interesting when tied back to DS, as this genetic disorder 
is associated with many signs of premature tissue aging including T-cell deficiency, and 





been tied to aging, including disorders such as Alzheimer’s and Parkinson’s disease (42) 
and cancer (43).  
 These results suggest a model in which over-expression of Sim2s regulates the 
cell cycle regulatory protein, p21, causing an arrest in the G2/M phase of the cell cycle.  
Additionally, up-regulation of p21 results in increased cellular senescence as shown by 
β-galactosidase staining and decreased Ki67 and increased H3K9Me2 expression in 
Western blot analysis.  In addition to this senescence there is an increase in apoptosis, 
and an increased sensitivity to DNA damaging reagents.  Thus, over-expression of 
Sim2s promotes a decrease in cellular growth, and decreased viability when treated with 
genotoxic reagents (Figure 21). 
Because the work presented here will be used as a foundation for future studies, 
several issues need to be addressed.  First, confirmation of up- or down-regulation of 
Sim2s by Western blot needs to be optimized.  While Real Time PCR shows an up-
regulation of the RNA (with over-expression), it is the stabilization of the protein that 
needs to be observed.  Secondly, cells over-expressing Sim2s are also seen to arrest in S-
phase.  Unfortunately we were unable to investigate this unique finding here, but future 
work will be done in this direction.  Thirdly, an alternative control (un-transduced MCF7 
cells) could have been used to fully verify these findings.  Finally, several of the assays 
presented here need to be repeated—especially Western blot analysis of H3K9Me2, as 
the findings are intriguing (with no observable expression in control cells and extreme 





Additionally, future work will delineate the mechanism by which Sim2s is 
activated by DNA damage and how this activation results in up-regulation of p21.  The 
role Sim2s plays in interacting with both p53 and p21 will be further clarified.  While we 
observed that p21 was induced in a p53- independent fashion, p53 was induced in MCF7 
cells in which Sim2s has been knocked-down across the board, while p53 was only 
active in Sim2s over-expressing cells in response to DNA damage.  The possible 
interaction with p53 is an extremely important aspect to examine.  Future work will also 
involve observing whether Sim2s is capable of directly interacting with p21 via ChIP 
and CoIP analysis.  Ultimately, understanding the mechanistic role Sim2s plays in 
response to DNA damage and cell cycle arrest will help us better understand its role as a 










Figure 21.  Proposed role of Sim2s in cell cycle arrest and cellular senescence.  
DNA damage results in induction of p21—perhaps by the transcription factor 
Sim2s.  Over-expression of Sim2s results in up-regulation of p21—which results 
in cell cycle arrest and cellular senescence.  In addition to this observed 
senescence, cells over-expressing Sim2s are sensitized to DNA damaging reagents, 
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